Skip to content

VC Ophthalmology

Active
Private limited companyfounded 2021active for 5 yearsPoederleesteenweg 42, 2460 Kasterlee, BelgiumKBO/BCE: BE 0772.896.592
Summary

VC Ophthalmology has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,500 and a net result of €157,086. Equity has been growing by about 113% per year since 2021. Its solvency ranks better than 5% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 26-08-2021 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.320.760.236 2460 Kasterlee, since 26-08-2021
Financial year end
31 December
Peppol
Reachable since 22-12-2025

Board and ownership

Board
  • VAN CAMP SophieDirector · since 26-08-2021

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€223,014
▼ 17.4%
Turnover
≈ €420,000
estimated
Profit
€157,086
▼ 21.4%
Equity
€2,500
▼ 99.3%
Total assets
€519,041
▼ 8.7%
Staff
≈ 0.1 FTE
estimated
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.97, cash €135,887, halvedFigures for financial year 2025 (filed on 10-03-2026)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 25% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 25-65
equity 0.5% of total assets
Liquidity 43-57
short-term debt 74.3% · cash 26.2%
Profitability 100=
return on assets 30.3%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026highest value 11-2026: 0.1%● unchanged vs 10-2026highest value
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 5% of them on solvency, 11% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 0.97, cash €135,887, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 10-03-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-03-2026, 147 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
147 days early
2024
1 day early
2023
35 days early
2022
68 days early
2021
8 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 49 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 June (4 of the last 5 accounts filed within 42 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €370,562 to €2,500 ▼ 99.3% View
  • Caution: Lower solvency than 95% of companies in human healthsector median 63.0% · 20,700 companies 0.5% View
  • Positive: 5 profitable years in a rowprofit 2025: €157,086 5 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Registered office moved from Kasterlee to Lichtaart
  2. · Gazette deed Incorporation
All 12 events

Comparable companies

These companies have the same main activity as VC Ophthalmology: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €510,000 and €547,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
VC Ophthalmology Kasterlee€519,041€223,014
L. Rutsaert Edegem€546,714€210,181
PJVDL Duffel€509,600€242,502
Park Dermatologie Herselt€514,901€252,533
Cabinet d’Anesthésie Dejonckheere Antoine Namur€546,543€227,216
Dr Isabelle DE QUIN Mons€518,270€227,039
OCULES Bekkevoort€532,581€235,167
Full comparison

Key facts about VC Ophthalmology

What is the company number of VC Ophthalmology?
The company number of VC Ophthalmology is 0772.896.592. The VAT number is the same number with BE in front: BE 0772.896.592.
Where is VC Ophthalmology based?
The registered office is at Poederleesteenweg 42, 2460 Kasterlee.Company details
What does VC Ophthalmology do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of VC Ophthalmology?
The legal form of VC Ophthalmology is Private limited company (BV).
When was VC Ophthalmology founded?
VC Ophthalmology was founded on 26-08-2021.
Is VC Ophthalmology still active?
Yes, VC Ophthalmology is an active enterprise in the KBO register.
What is the turnover of VC Ophthalmology?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €223,014 and 43 comparable companies (NACE 86220). It probably lies between €350,000 and €550,000.Financials
Is VC Ophthalmology profitable?
In financial year 2025, VC Ophthalmology made a profit of €157,086.
Where can I find the annual accounts of VC Ophthalmology?
VC Ophthalmology filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VC Ophthalmology due?
VC Ophthalmology must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.